Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.100
-0.030 (-2.65%)
At close: May 12, 2025, 4:00 PM
1.110
+0.010 (0.91%)
After-hours: May 12, 2025, 5:42 PM EDT
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.88, with a low estimate of 2.00 and a high estimate of 7.50. The average target predicts an increase of 252.73% from the current stock price of 1.10.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Lucid Diagnostics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7 → $7.5 | Strong Buy | Maintains | $7 → $7.5 | +581.82% | Apr 21, 2025 |
| Needham | Needham | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +172.73% | Apr 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $2 | Buy | Reiterates | $2 | +81.82% | Mar 26, 2025 |
| Needham | Needham | Strong Buy Maintains $2.5 → $3 | Strong Buy | Maintains | $2.5 → $3 | +172.73% | Mar 24, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.25 → $7 | Strong Buy | Maintains | $7.25 → $7 | +536.36% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
9.03M
from 4.35M
Increased by 107.75%
Revenue Next Year
29.92M
from 9.03M
Increased by 231.37%
EPS This Year
-0.58
from -1.05
EPS Next Year
-0.35
from -0.58
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.2M | 50.9M | 61.6M | ||
| Avg | 9.0M | 29.9M | 43.4M | ||
| Low | 6.2M | 11.9M | 25.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 180.3% | 463.5% | 106.0% | ||
| Avg | 107.8% | 231.4% | 44.9% | ||
| Low | 42.1% | 31.4% | -13.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.49 | -0.26 | -0.09 | ||
| Avg | -0.58 | -0.35 | -0.09 | ||
| Low | -0.77 | -0.50 | -0.08 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.